- Home
- MREO vs AIP Comparison
MREO vs AIP Comparison
Compare MREO & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- AIP
- Stock Information
- Founded
- MREO 2015
- AIP 2003
- Country
- MREO United Kingdom
- AIP United States
- Employees
- MREO N/A
- AIP N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- MREO Health Care
- AIP Technology
- Exchange
- MREO Nasdaq
- AIP Nasdaq
- Market Cap
- MREO 438.8M
- AIP 400.9M
- IPO Year
- MREO N/A
- AIP 2021
- Fundamental
- Price
- MREO $1.74
- AIP $9.39
- Analyst Decision
- MREO Strong Buy
- AIP Strong Buy
- Analyst Count
- MREO 5
- AIP 3
- Target Price
- MREO $7.20
- AIP $15.00
- AVG Volume (30 Days)
- MREO 1.8M
- AIP 2.1M
- Earning Date
- MREO 08-12-2025
- AIP 08-05-2025
- Dividend Yield
- MREO N/A
- AIP N/A
- EPS Growth
- MREO N/A
- AIP N/A
- EPS
- MREO N/A
- AIP N/A
- Revenue
- MREO $500,000.00
- AIP $63,236,000.00
- Revenue This Year
- MREO N/A
- AIP $19.82
- Revenue Next Year
- MREO $38.38
- AIP $17.29
- P/E Ratio
- MREO N/A
- AIP N/A
- Revenue Growth
- MREO N/A
- AIP 18.64
- 52 Week Low
- MREO $1.47
- AIP $5.46
- 52 Week High
- MREO $5.02
- AIP $14.29
- Technical
- Relative Strength Index (RSI)
- MREO 44.98
- AIP 48.62
- Support Level
- MREO $1.64
- AIP $8.98
- Resistance Level
- MREO $1.78
- AIP $10.46
- Average True Range (ATR)
- MREO 0.09
- AIP 0.86
- MACD
- MREO 0.04
- AIP -0.10
- Stochastic Oscillator
- MREO 87.10
- AIP 11.39
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.